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Method for preparing Gene Expression Profile 
Technical Field 
5 
The present invention relates to a method for preparing a gene 
expression profile.  
Background Art 
10 
In the year 2002, the human genome sequence has been decoded 
almost completely. From the obtained data of bases, the developments 
of tailor-made therapies and so on have been expected. For this 
purpose, it is very important to identify genes and determine the degree of 
15 their expression in vivo, or to elucidate the network of gene expression.  
In addition, for elucidating the gene-expression network, there is a need 
for making a gene expression profile, which identifies genes being 
expressed and determines the degree of their expression in vivo at a 
specified time.  
20 At present, methods for preparing a gene expression profile 
include a differential display method, a serial analysis of gene expression 
(SAGE), a method using a micro-array or a DNA chip, a method of 
high-coverage expression profiling (HiCEP) disclosed in the International 
Publication WO 02/48352 A1, etc.  
25 Among these methods for preparing a gene expression profile, the 
HICEP method is an excellent one in that the gene expression profile can 
be easily prepared for covering a wide variety of genes including unknown 
genes.  
1
In a PCR reaction used as one of the steps in the HiCEP method, 
the temperature used for annealing a primer to a template is 
conventionally around the melting temperature (Tm) of the primer, for 
example, 550C when each primer used was composed of a 20mer with a 
5 50% GC content ("Protocol 15: Quantitative PCR 8.86" in Sambrook and 
Russell, "Molecular Cloning", 3rd Ed., Cold Spring Harbor Laboratory 
Press (U.S.A.), 2001).  
The expression level of a gene varies depending on the kinds of 
genes and the expression timing thereof. Therefore, for elucidating the 
10 gene expression network, a method for preparing a gene expression 
profile, as a prerequisite thereof, is desired to have high detection 
sensitivity to expressed genes.  
Accordingly, for a HiCEP method capable of preparing a gene 
expression profile covering a wide variety of genes in a simple manner, 
15 the present inventor has intensively studied for a further improvement in 
the sensitivity of detecting expressed genes.  
Disclosure of the Invention 
As a result, in the PCR reaction step of the HiCEP method, the 
present inventor has found that a dramatic improvement in the detection 
20 sensitivity of expressed genes can be attained by setting the annealing 
temperature of a primer to a template used in the PCR reaction in a 
particular range. The present invention has been accomplished based 
on these findings.  
That is, the present invention is a method for preparing a gene 
25 expression profile, which is characterized by comprising: 
(a) synthesizing a single-stranded cDNA by using a poly(A) RNA 
as a template, wherein the single-stranded cDNA bearing a tag substance 
at the 5'-end side relative to the single-stranded cDNA is synthesized; 
2
(b) synthesizing a double-stranded cDNA by using the 
single-stranded cDNA synthesized in the step (a) as a template, wherein 
the double-stranded cDNA bearing a tag substance at the 3'-end side 
relative to the double-stranded cDNA is obtained; 
5 (c) cleaving the double-stranded cDNA obtained in the step (b) 
with a first restriction enzyme X; 
(d) recovering a fragment bearing the tag substance from 
fragments obtained in the step (c) by using a substance having a high 
affinity for the tag substance; 
10 (e) iigating an adaptor X containing a sequence complementary to 
the sequence of the cleavage site and a sequence complementary to the 
sequence of a primer X to the cleavage site of the fragment generated by 
the first restriction enzyme X as recovered in the step (d), to obtain a 
fragment ligated with the adaptor X at the 5'-end side relative to the 
15 double-stranded cDNA; 
(f) cleaving the fragment recovered in the step (e) with a second 
restriction enzyme Y that does not cleave the adaptor X; 
(g) removing a fragment bearing the tag substance from the 
fragments obtained in the step (f) by using a substance having a high 
20 affinity for the tag substance, to recover a fragment containing the 
cleavage site generated by the second restriction enzyme Y at the 3'-end 
side relative to the double-stranded cDNA; 
(h) ligating an adaptor Y containing a sequence complementary to 
the sequence of the cleavage site and a sequence complementary to the 
25 sequence of a primer Y to the cleavage site of the fragment generated by 
the second restriction enzyme Y as recovered in the step (g), to obtain a 
fragment of a double-stranded sequence ligated with the adaptor Y at the 
3'-end side relative to the double-stranded cDNA; 
3
(i) performing a PCR reaction with the fragment of the 
double-stranded sequence obtained in the step (h) as a template by using 
a primer set composed of a primer X containing a sequence 
complementary to the sequence of the adaptor X, which has the 
5 sequence of 2 bases N1N2 (N1 and N2 may be identical or different bases 
that are selected from the group consisting of adenine, thymine, guanine 
and cytosine) at the 3' end relative to the primer X, and a primer Y 
containing a sequence complementary to the sequence of the adaptor Y, 
which has the sequence of 2 bases N3N4 (N3 and N4 may be identical or 
10 different bases that are selected from the group consisting of adenine, 
thymine, guanine and cytosine) at the 3' end relative to the primer Y; and 
(j) subjecting the obtained PCR product to electrophoresis and 
detecting the migration distance and peaks to prepare a gene expression 
profile, 
15 wherein, in the step (i), the annealing of the primer X and the 
primer Y to the adaptor X and the adaptor Y respectively is carried out in 
the temperature range of TmMAX + 60C to TmMAX + 14*C of the primers.  
Brief Description of the Drawings 
20 
FIG. 1 is a schematic diagram showing a method for preparing a 
gene expression profile, which is one embodiment of the present 
invention; 
25 FIG. 2 is a diagram showing a gene expression profile prepared 
according to the present invention; and 
FIG. 3 is a graph showing the relationship between the annealing 
4
temperature and the fluorescent intensity of peaks.  
Best Mode for Carrying Out the Invention 
5 A method for preparing the gene expression profile of the present 
invention will be described with reference to FIG. 1 as one embodiment.  
The alphabets of the above-mentioned steps from (a) to (j) correspond to 
those of steps (a) to (j) in FIG. 1, respectively.  
Each of the alphabets of sequences shown in FIG. 1 represents a 
10 base constituting a base sequence. A represents adenine (hereinafter, 
abbreviated to A); G represents guanine (hereinafter, abbreviated to G); C 
represents cytosine (hereinafter, abbreviated to C); and T represents 
thymine (hereinafter, abbreviated to T). N1, N2 , N3 , and N4 each may be 
identical or different, which are bases selected from the group consisting 
15 of A, C, G, and T.  
In the description of the present invention, the 5'-end side of a 
sense strand (a strand having a sequence homologous to a poly(A) RNA 
as a template) of a double-stranded cDNA is given as the 5' end of the 
double-stranded cDNA and the 3' end of the sense sequence is given as 
20 the 3' end of the double stranded cDNA unless otherwise specified herein.  
Step (a) 
In this step, a poly(A) RNA is used as a template to synthesize a 
single-stranded cDNA.  
25 First, a poly(A) RNA 11 is extracted from a cell targeted for 
preparing a gene expression profile.  
An oligo dT primer complementary to a poly(A) tail at the 3'-end 
side of the extracted poly(A) RNA 11, which is labeled with a tag 
5
substance 12, is used as a primer to synthesize a single-stranded cDNA 
13 (shown together with the poly(A) RNA 11 in FIG. 1) with the poly(A) 
RNA 11 as a template. The tag substance 12 is added at the 5'-end side 
relative to the single-stranded cDNA 13.  
5 
Step (b) 
The single-stranded cDNA 13 synthesized in the step (a) is used 
as a template to synthesize a double-stranded cDNA 14. The tag 
substance 12 is added at the 3'-end side relative to the double-stranded 
10 cDNA 14.  
Step (c) 
The double-stranded cDNA 14 obtained in the step (b) is cleaved 
with a first restriction enzyme X.  
15 
Step (d) 
Using a substance 15 having a high affinity for the tag substance 
12, the tag substance 12 is captured to recover a fragment bearing the 
tag substance 12 from the fragments obtained in the step (c).  
20 
Step (e) 
To a cleavage site of the fragment generated by the first restriction 
enzyme X as recovered in the step (d), an adaptor X 16 containing a 
sequence complementary to the sequence of the cleavage site and a 
25 sequence complementary to the sequence of a primer X is ligated to 
obtain a fragment ligated with the adaptor X 16 at the 5'-end side relative 
to the double-stranded cDNA 14.  
6
Step (f) 
The fragment recovered in the step (e) is cleaved with a second 
restriction enzyme Y.  
5 Step (g) 
The substance 15 having a high affinity for the tag substance 12 is 
used to remove a fragment bearing the tag substance 12 from the 
fragments obtained in the step (f), thereby recovering a fragment 
containing a cleavage site by the second restriction enzyme Y at the 
10 3'-end side relative to the double-stranded cDNA 14.  
Step (h) 
To the cleavage site of the fragment generated by the second 
restriction enzyme Y as recovered in the step (g), an adaptor Y 17 
15 containing a sequence complementary to the sequence of the cleavage 
site and a sequence complementary to a primer Y is ligated to obtain a 
fragment 18 of a double-stranded sequence ligated with the adaptor Y 17 
at the 3'-end side relative to the double stranded cDNA 14. The obtained 
fragment 18 of the double-stranded sequence contains the adaptor X 16 
20 at the 5'-end side and the adaptor Y 17 at the 3'-end side relative to the 
double-stranded cDNA 14.  
Step (i) 
Using a primer set composed of a primer X 19 containing a 
25 sequence complementary to the sequence of the adaptor X 16, which has 
the sequence of 2 bases N1N2 (wherein N1 and N2 may be identical or 
different bases that are selected from the group consisting of A, T, G, and 
C) at the 3' end (i.e., at the amplification side) relative to the primer X 19 
7
and is bonded with a fluorescent substance 20 at the 5' end relative to the 
primer X 19, and a primer Y 21 containing a sequence complementary to 
the sequence of the adaptor Y 17, which has the sequence of 2 bases 
N3 N4 (wherein N3 and N4 may be identical or different bases that are 
5 selected from the group consisting of A, T, G, and C) at the 3' end (i.e., at 
the amplification side) relative to the primer Y 21, a PCR reaction is 
carried out with the fragment 18 of the double-stranded sequence 
obtained in the step (h) as a template.  
Here, the temperature for annealing the primer set to the template is in 
10 the range of Tm MAX + 60C to Tm MAX + 14°C of the primers.  
Step (i) 
The obtained PCR product is subjected to electrophoresis to 
detect the migration distance and peaks, and a gene expression profile is 
15 prepared.  
In the present specification, a "gene expression profile" refers to 
any of those showing information such as an expression pattern of a gene 
in a specified cell under certain conditions, the presence or absence of an 
expression of a known or unknown gene, the expression level of all genes 
20 being expressed, etc. In addition, the gene expression profile may be 
utilized as a means for analyzing the expression of genes.  
A "poly(A) RNA" refers to an mRNA having a sequence called 
generally polyA at the 3' end. Moreover, a cDNA can be synthesized 
from the poly(A) RNA with an "oligo dT primer" having a sequence 
25 complementary to the poly(A) RNA. Generally, the "oligo dT primer" 
used here is also referred to as an oligo(dT) primer. The synthesis of a 
single-stranded cDNA from the poly(A) RNA using the oligo dT primer 
(step (a)) may be achieved under any of generally employed conditions.  
8
The synthesis of a double-stranded cDNA from the single-stranded cDNA 
(step (b)) may also be achieved under any of generally employed 
conditions.  
A "tag substance" or a "substance having a high affinity for the tag 
5 substance" refers to either of substances constituting a binding pair 
capable of specifically binding to each other with a high affinity. In the 
method shown in Example 1 according to one embodiment of the present 
invention, biotin as the tag substance and streptavidin as the substance 
having a high affinity for the tag substance are used, but not limited to 
10 them. Any of binding pairs capable of specifically binding to each other 
with a high affinity may be used. Examples of the combination of the tag 
substance with the substance having a high affinity for the tag substance 
available in the present invention include, but not limited to, biotin and 
streptavidin, biotin and avidin, FITC and a FITC antibody, DIG and 
15 anti-DIG, Protein A and mouse IgG, latex particles, etc. The addition of 
the tag substance to a DNA sequence may be achieved under any of 
generally employed conditions. Furthermore, the recovery of a DNA 
fragment based on an affinity between the "tag substance" and the 
"substance having a high affinity for the tag substance" (steps (d) and (g)) 
20 may be achieved under any of generally employed conditions.  
A "restriction enzyme" is an enzyme generally called as a 
restriction endonuclease, which hydrolyzes and cleaves a 
double-stranded DNA in a certain sequence. In the present invention, for 
obtaining suitable fragments, two restriction enzymes X and Y are utilized 
25 in combination. It is preferable that a restriction enzyme useful in the 
present invention is an enzyme capable of cleaving a double-stranded 
cDNA synthesized from an expressed gene, that is, an mRNA, into 
fragments each having a recognizable length. Also preferable is an 
9
enzyme capable of cleaving as many of the obtained double strands as 
possible, preferably almost all of the double strands. Examples of such 
an enzyme are shown in Table 1 described below.  
Restriction Recognition Restriction Recognition 
Enzyme Name Site of Enzyme Name Site of 
Restriction Restriction 
Enzyme Enzyme 
Accil CG/CG Hpall C/CGG 
Afal GT/AC Hsp9211 CATG/ 
Alul AG/CT HspAl G/CGC 
AspLEI GCG/C Kzo91 /GATC 
Bfal C/TAG Mael C/TAG 
BscFI /GATC Mbol /GATC 
Bsh12361 CG/CG Msel T/TAA 
BshI GG/CC Mspl C/CGG 
BsiSI C/CGG MvnI CG/CG 
Bspl431 /GATC Ndell /GATC 
BstUI CG/CG Nlalll CATG/ 
BsuRI GG/CC Pall GG/CC 
Cfol GCG/C Rsal GT/AC 
Csp61 G/TAC Sau3Al /GATC 
Dpnll /GATC Sse91 /AATT 
FnuDII CG/CG Tagi T/CGA 
Haelll GG/CC Thal CG/CG 
Hapil C/CGG Trull T/TAA 
Hhal GCG/C Tru91 T/TAA 
Hin21 C/CGG Tsp5091 /AATT 
Hin61 G/CGC TspEl /AATT 
HinP1l G/CGC TthHB81 T/CGA 
5 
Any two of enzymes may be selected from enzymes of Table 1 
and used in combination. Also, although enzymes shown in Table 1 are 
enzymes recognizing 4 bases, other enzymes recognizing 4 bases or 
enzymes recognizing 6 bases may be used. In the present invention, it 
10 is preferable to use the enzyme recognizing 4 bases and it is particularly 
preferable to use a combination of Mspl and Msel. In the method shown 
in Example 1 according to one embodiment of the present invention, Mspl 
10
is used as the restriction enzyme X and Msel is used as the restriction 
enzyme Y, but the enzymes are not limited to them. The cleavage of a 
double-stranded DNA by the restriction enzyme (steps (c) and (f)) may be 
achieved under any of generally employed conditions.  
5 An "adaptor" is used for binding of a primer used in a PCR 
reaction in the step (i). The adaptor is designed in accordance with 
restriction enzymes and primers used. That is, an adaptor X to be 
ligated to a recognized cleavage site of a restriction enzyme X contains a 
sequence complementary to the recognized cleavage site of the 
10 restriction enzyme X and further has a sequence complementary to the 
sequence of a primer X. Preferably, the adaptor X can be designed to 
have around 30 bases. This enables performing a stable PCR. An 
adaptor Y to be ligated to a recognized cleavage site of a restriction 
enzyme Y contains a sequence complementary to the recognized 
15 cleavage site of the restriction enzyme Y and further has an arbitrary 
sequence complementary to a primer Y. Preferably, the adaptor Y can 
be designed to have around 30 bases. This enables performing a stable 
PCR.  
In the method of Example 1 according to one embodiment of the 
20 present invention, as the adaptor X, those containing a sequence 
complementary to a cleavage site by the restriction enzyme Mspl (SEQ ID 
NOs: 1 and 2), and, as the adaptor Y, those containing a sequence 
complementary to a cleavage site by the restriction enzyme Msel (SEQ ID 
NOs: 3 and 4) are used, but the adaptors are not limited to them. The 
25 binding of the adaptor to a double-stranded DNA (steps (e) and (h)) may 
be achieved under any of generally employed conditions.  
In each of X- and Y-primer sequences which constitute a set of 
primers used in a PCR reaction in the step (i), the sequence of the part of 
11
each primer other than the two-base sequence part (N1N2 for the primer X 
and N3N4 for the primer Y) at the 3' end of each primer is desired not to 
coincide with the sequence of a subject RNA. However, it is difficult to 
satisfy this condition because the whole RNA sequence has not been 
5 elucidated in any organisms until now. Therefore, for example, if a 
human subject is used for study, it is preferable to select a sequence 
which is absent or occurring with an extremely low frequency in the 
human genome sequence.  
For satisfying the above-described condition, it is preferable that 
10 the primer X and the primer Y each have a length of 16 bases or more.  
For example, if a primer is designed with a length of 16 bases under the 
circumstance that the human genome sequence has a length of 
approximately 3 billion bases, 4 to the 16th power of (approximately 4 
billion different) primers are made possible from 4 bases (A, C, G, and T) 
15 constituting the primer, and therefore an arbitrary.primer having 16 bases 
selected from these primers will occur in the human genome sequence 
with the frequency of 1 or less. Thus, by comparing the sequence of a 
primer having a length of 16 bases or more designed in consideration of 
general conditions required for a primer, which will be described below, 
20 with the sequences registered in a publicly available base sequence 
database, a primer having a sequence not coinciding with the sequences 
present in the human genome or a sequence occurring with an extremely 
low frequency can be selected.  
Besides, a primer used in the step (i) has to satisfy conditions 
25 generally required for a PCR primer (e.g., conditions described in Hiroki 
Nakayama, "Bio Experiment Illustrated (3), New Edition, PCR capable of 
really amplifying (Hontouni Fueru PCR in Japanese)," 2nd Ed., Fourth 
impression, Shunjunsha, 2002): 
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1. Formation of a primer-dimer is not expected to occur between primers 
X, between primers Y, and between a primer X and a primer Y; 
2. Formation of a higher-order intramolecular structure is not expected to 
occur in a primer X and in a primer Y; and 
5 3. Complementarity of 5'-end sequences is not expected to occur between 
primers X, between primers Y, and between a primer X and a primer Y.  
For a Tm value of the primer, because the Tm value defines an 
annealing temperature (from TmMAX + 60C to TmMAX + 140C of the 
primer), the annealing temperature increases as the Tm value of the 
10 primer increases. Therefore, the Tm value of the primer is preferably 
equal to or lower than the maximum temperature minus 60C at which a 
heat resistant polymerase being used sufficiently functions throughout the 
whole reaction time in a PCR reaction, so that the annealing temperature 
does not exceed the temperature at which the heat resistant polymerase 
15 can sufficiently function throughout the whole reaction time in the PCR 
reaction. Accordingly, it is preferable that the Tm values of primers X 
and Y used in the step (i) each are in the range of 590C to 690C, 
especially in the range of 600C to 640C. When the Tm value of each of 
the primer X and the primer Y is in the range of 60 to 640C, a PCR 
20 reaction can be carried out with an annealing temperature (from TmMAX 
+ 60C to TmMAX + 140C) described below to obtain substantially high 
detection sensitivity of expressed genes.  
The sequence of 2 bases at the 3'-end side of each of primers X 
and Y (N1N 2 for the primer X and N3N4 for the primer Y) may be identical 
25 or different, which are bases selected from the group consisting of 
adenine, thymine, guanine and cytosine.  
The primer X and the primer Y can be synthesized using a general 
method for synthesizing primers, for example, the chemical synthesis 
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method of oligonucleotides by a phosphoramidite approach (Letsinger et.  
al., Nucleic Acids Research, 20, 1879-1882, 1992) and a method 
described in Unexamined Japanese Patent Publication No.11-08018.  
Moreover, for facilitating detection after a PCR reaction, it is 
5 preferable to previously bind a fluorescent substance to the end of either 
of the primers. Preferably, the fluorescent substance is bonded to the 5' 
end of the primer X. A fluorescent substance that may be used in the 
present invention includes 6-carboxyfluorescein (FAM), 
4,7,2',4',5',7'-hexachloro-6- carboxyfluorescein (HEX), NED (Applied 
10 Biosystems, Japan), 6-carboxy-X-rohdamine (Rox), etc.  
A "primer set" refers to one set of primers composed of a primer X 
and a primer Y used for carrying out a PCR reaction with a fragment of a 
double-stranded sequence obtained in the step (h) as a template.  
Here, in the case of using, as the primers X and Y constituting the primer 
15 set, primers each having a fixed structure of sequences other than the 
sequence of 2 bases (N1N2 for the primer X and N3N4 for the primer Y) at 
the 3'-end side of each primer sequence (e.g., an Mspl primer shown in 
SEQ ID NO.: 5 as a primer X used in Example 1, and a Msel primer 
shown in SEQ ID NO.: 6 as a primer Y used in Example 1), 16 different 
20 primers X and 16 different primers Y can be obtained depending on the 
kinds of bases constituting the 2-base sequence. Combinations of these 
primers X and Y result in 256 different primer sets. It is preferable to use 
such 256 different primer sets because gene expression profiles covering 
the expression of almost all of genes can be prepared in a simple manner.  
25 The step (j), a means "subjecting the obtained PCR product to 
electrophoresis and detecting the migration distance and peaks to 
prepare a gene expression profile" may be any of those capable of 
measuring the molecular weight (the length of a base sequence) and the 
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quantity of an amplified PCR product. Among them, electrophoresis is 
preferable in terms of high resolution, and gel electrophoresis is 
particularly preferable. When gel electrophoresis is used, a gel 
electrophoresis device can be combined with analysis software to obtain 
5 the results of gel electrophoresis as a peak pattern that is an indicator of 
the migration distance and the quantity of the separated PCR 
amplification product. In this peak pattern, the migration distance of an 
amplified PCR product reflects a certain gene and the quantity of the 
amplified PCR product reflects the expression level of the gene.  
10 Accordingiy, the peak pattern is given as a gene expression profile itself.  
As the gel electrophoresis device, for example, ABI PRISM 3100 
(Applied Biosystems, Japan), ABI PRISM 3700 (Applied Biosystems, 
Japan), and MegaBASE 1000 (Amersham Pharmacia), which are called 
as a sequencer, can be used. As the analysis software, for example, 
15 GeneScanTM (Applied Biosystems, Japan) can be used.  
Furthermore, it is noted that each of the above-described steps 
can be also carried out according to a method described in the 
International Publication WO 02/48352 Al.  
In addition, the magnitude of a peak which appears on the gene 
20 expression profile prepared according to the present invention reflects the 
expression level of a gene expressed in a subject cell. Thus, the 
frequency of the gene expression can be analyzed by observing changes 
in the magnitude of the peak. It is possible to carry out, for example, 
comparison between a normal cell and an abnormal cell, comparison 
25 between a normal cell and a canceer cell, comparison between different 
cells, comparison between cells treated under different conditions, etc.  
Hereinafter, an annealing temperature in the step (i) that 
characterizes the present invention will be described in detail.  
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In a PCR reaction of the step (i), the annealing of a primer set to 
templates, that is, the annealing of a primer X and a primer Y constituting 
the primer set to each of the corresponding strands of a fragment of a 
double-stranded sequence obtained in the step (h) is carried out in the 
5 temperature range of TmMAX + 60C to TmMAX + 14°C of the primer, 
preferably in the range of TmMAX + 6°C to TmMAX + 100C of the primer, 
and most preferably in the range of TmMAX + 60C to TmMAX + 90 C of the 
primer.  
Here, the "TmMAX" of the primer refers to the larger one of the Tm 
10 values of a primer X and a primer Y constituting a pririer set.  
Moreover, the "Tm" of the primer refers to a temperature at which a 
double strand formed by a primer and an adaptor is unraveled. Tm can 
be experimentally determined according to a method described in, for 
example, Shoji Mizushima, Tairo Oshima, et. al., "Basic Experiment of 
15 Life Science (Raifu Saiensu no Kiso Jikken in Japanese)", Maruzen.  
Alternatively, if the number of bases constituting a primer is less than 20, 
Tm can be calculated most easily according to, for example, the following 
formula described in Chapter 10.3 in Sambrook and Russel, "Molecular 
Cloning" 3rd Ed., Cold Spring Harbor Laboratory Press (U.S.A.), 2001: 
20 Tm (oC) = 2 x (A + T) + 4 x (G + C) (Formula 1), 
wherein (A + T) is the sum of the numbers of adenine (A) and thymine (T) 
residues constituting a primer; and (G + C) is the sum of the numbers of 
cytosine (C) and guanine (G) residues.  
As described above, although Tm can be experimentally and 
25 computationally determined and there are various methods for 
determination, any of the methods can be utilized as long as the same 
method is used to determine Tm of a primer X and Tm of a primer Y.  
If several different primer sets are simultaneously used, the 
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largest one of the Tm values of a primer X and a primer Y constituting 
each primer set used is given as TmMAX. When the annealing of the 
primer set of the present invention is carried out in the temperature range 
of TmMAX + 6°C to TmMAX + 140C of the primer, misannealing can be 
5 avoided, resulting in an improvement of the detection sensitivity of an 
expressed gene.  
It is noted that if only the correct annealing of primers to templates 
is desired, this purpose is considered to be attained by using an 
annealing temperature of TmMAX + 60 C or more of the primer.  
10 However, the enzyme activity of a heat resistant polymerase used 
in a PCR reaction is affected by temperature and the heat resistant 
polymerase is reduced in function under high temperatures at which 
enzymes are denatured (e.g., 90 0 C or more for a Taq polymerase), 
leading to the reduction in the efficiency of the PCR reaction. Thus, it is 
15 necessary to set the annealing temperature at or below the temperature 
at which a heat resistant polymerase can sufficiently function throughout 
the whole reaction time in the PCR reaction (e.g., 75 0C for the Taq 
polymerase).  
In light of the foregoing, in the present invention, an annealing 
20 temperature in the step (i) is set in the temperature range of TmMAX + 
60C to TmMAX + 140C of the primer, and preferably in the range of 
TmMAX + 60C to TmMAX + 90C of the primer, at which the correct 
annealing of primers to templates can be attained while a heat resistant 
polymerase can sufficiently function and a substantial improvement of 
25 detection sensitivity of an expressed gene can be accomplished.  
Incidentally, as the conditions of a PCR reaction except for the 
above-mentioned annealing temperature, conditions employed generally 
for a PCR reaction can be used.  
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In Example 1 according to one embodiment of the present 
invention, as a primer X, a primer having a sequence complementary to 
an adaptor X containing a sequence complementary to a cleavage site by 
a restriction enzyme Mspl (SEQ ID NO.: 5), and as a primer Y, a primer 
5 having a sequence complementary to an adaptor Y containing a sequence 
complementary to a cleavage site by a restriction enzyme Msel (SEQ ID 
NO.: 6) are used. In this case, the Tm values of the primer X and the 
primer Y calculated according to the above formula (1) are in the range of 
600 to 64°C (i.e., TmMAX = 64 0C), and thus the annealing temperature is 
10 in the range of 70'C (TmMAX + 6'C) to 780C (TmMAX + 140C), but not 
limited to them.  
In the preferred embodiment of the present invention, in the step 
(i), 
by using an adaptor having sequences shown in SEQ ID Nos: 1 and 2 as 
15 an adaptor X, and an adaptor having sequences shown in SEQ ID NOs:3 
and 4 as a primer Y, and 
by using 256 different primer sets composed of, a primer having a 
sequence shown in SEQ ID NO: 5 as a primer X and a primer having a 
sequence shown in SEQ ID No: 6 as a primer Y, 
20 a PCR reaction is carried out at the temperature for annealing 
primers in the range of 700C (TmMAX + 60C) to 730C (TmMAX + 90C).  
(Examples) 
Next, the effect of the present invention will be specifically 
25 explained with reference to examples. However, the present invention is 
not intended to be limited to them.  
As an indicator of the detection sensitivity of an expressed gene, 
the presence of a false peak in a gene expression profile is adopted.  
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A peak in the gene expression profile is a peak that corresponds 
to the quantity of a PCR product (a gene transcript) obtained by 
amplification in a PCR reaction of the step (i) of the present invention, 
and can be detected based on, for example, a fluorescent dye bonded to 
5 the 5'-end side of a primer X.  
A false peak refers to a peak generated by misannealing of 2 
bases (N1N2 for a primer X and N3N4 for a primer Y) at the 3' end of each 
of the primers constituting a primer set to a respective noncomplementary 
base sequence. The presence of the false peak means that, although 
10 essentially one gene transcript should be detected by a single peak (a 
true peak) generated by a specific single primer set containing a 
sequence complementary to the gene transcript, an additional peak is 
also generated by another primer set that is not complementary (a false 
peak), resulting in a state of several peaks generated for one gene 
15 transcript. The presence of such several peaks for one gene transcript 
affects the detection sensitivity of an expressed gene. As a result, this 
complicates analytical procedures for gene expression based on the gene 
expression profile. Thus, a method to suppress false peaks or a method 
to exclude false peaks from the analysis by distinguishing them is 
20 required. The method of the present invention is to improve the 
detection sensitivity of an expressed gene with the suppression of the 
occurrence of false peaks by setting the kind of primers to be used in 
PCR reaction and the annealing temperature of the primers to templates 
to a particular range.  
25 
Method of evaluating genuineness of peak 
The genuineness of a peak was evaluated by comparing the base 
sequence of an amplified PCR product corresponding to a certain gene 
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obtained by using primers having known sequences, with the base 
sequence of the gene having a known sequence registered in the existing 
database to determine whether or not there is a coincidence between the 
portions in both of the base sequences corresponding to 2 bases (N1N2 
5 for a primer X and N3N4 for a primer Y) at the 3' end of each of the 
primers.  
Specifically, the genuineness of a peak was evaluated according 
to the following procedures: 
1. Using a certain primer set composed of primers X and Y 
10 having known sequences, a gene expression profile was prepared by a 
HiCEP method to determine the sequence of an amplified PCR product 
corresponding to a peak appearing in the profile.  
2. A region corresponding to the base sequences of the primers 
15 X and Y used was identified from the sequence of the amplified PCR 
product, and only the portion of a base sequence containing the identified 
regions and sandwiched between these regions was selected, for which a 
computer-based homology search of base sequences (BLAST) was 
performed with respect to the existing database. The genuineness was 
20 then evaluated for three criteria (1) to (3) described below.  
Incidentally, a "sense strand of a gene registered in the database" 
in the "base sequence of the gene registered in the database" mentioned 
in the description below refers to a strand having a sequence homologous 
to the sense strand of a fragment of a double-stranded sequence 
25 obtained in the step (h), which is to be used as a template in the PCR 
reaction. An "antisense strand of the gene registered in the database" 
refers to a strand having a sequence homologous to the antisense strand 
of the fragment of the double-stranded sequence obtained in the step (h), 
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which is to be used as a template in the PCR reaction.  
In addition, a "sense strand of an amplified PCR product" in the 
"amplified PCR product" mentioned in the description below refers to a 
strand having a sequence homologous to the sense strand of a fragment 
5 of a double-stranded sequence obtained in the step (h), which is to be 
used as a template in the PCR reaction, and an "antisense strand of the 
amplified PCR product" refers to a strand having a sequence homologous 
to the antisense strand of the fragment of the double-stranded sequence 
obtained in the step (h), which is to be used as a template in the PCR 
10 reaction.  
(1) The base sequences of the sense strand and the antisense 
strand of the amplified PCR product identified by the homologous search 
(however, except for the portion corresponding to each primer) each 
agree 100% with the base sequences of the sense strand and the 
15 anti-sense strand of a certain gene (all or a portion of) registered in the 
database.  
(2) In the sense strand of the amplified PCR product, the 
recognition sequence of a restriction enzyme X is present in the proximity 
of the 5'-end side of the region having the agreement obtained in (1), and 
20 in the antisense strand of the amplified PCR product, the recognition 
sequence of a restriction enzyme Y is present in the proximity of the 
5'-end side of the region having the agreement obtained in (1).  
(3) The sequence of 2 bases (corresponding to the base sequence 
of N1N2 of the primer X) at the 3'-end side immediately adjacent to the 
25 recognition sequence of the restriction enzyme X in the sense strand of 
the amplified PCR product evaluated in (2) agrees with the sequence of 2 
bases (corresponding to the base sequence of N1N2 of the primer X) at 
the 3'-end side immediately adjacent to the recognition sequence of the 
21
restriction enzyme X in the sense strand of the gene registered in the 
database, and the sequence of 2 bases (corresponding to the base 
sequence of N3N4 of the primer Y) at the 3'-end side immediately adjacent 
to the recognition sequence of the restriction enzyme Y in the antisense 
5 strand of the amplified PCR product evaluated in (2) agrees with the 
sequence of 2 bases (corresponding to the base sequence of N3N4 of the 
primer Y) at the 3'-end side immediately adjacent to the recognition 
sequence of the restriction enzyme Y in the antisense strand of the gene 
registered in the database.  
10 
3. If an amplified PCR product constituting a certain peak 
satisfied all of the above-mentioned three conditions, the peak was 
judged to be a true peak, as obtained based on the correct annealing of 
primers.  
15 On the other hand, there is a peak composed of a PCR product 
that satisfies the above conditions (1) and (2) but not the condition (3).  
If an amplification reaction proceeds based on correct annealing, an 
"amplified PCR product" and a "gene registered in the database" should 
have identical sequences in the portion corresponding to the sequence of 
20 2 bases (N1N2 for the primer X and N3N4 for the primer Y) at the 3'-end 
side of each of primers. On the other hand, if an amplification reaction 
proceeds based on misannealing, a final "amplified PCR product" and a 
"gene registered in the database" are to have different sequences in the 
portion corresponding to the sequence of 2 bases at the 3'-end side of 
25 each of primers, because the amplification reaction further proceeds in 
subsequent cycles thereof using the primer that has caused misannealing 
as a template. Therefore, an "amplified PCR product" having a different 
sequence in the portion corresponding to the sequence of 2 bases at the 
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3'-end side of each primer from that of a "gene registered in the 
database" (i.e., a PCR product that does not satisfy the condition (3)) was 
concluded to be a PCR product obtained from the misannealing of 
primers, and thus a peak constituting such a PCR product was judged to 
5 be a false peak.  
Example 1 
For mouse embryonic fibroblasts (MEF), a gene expression profile 
was prepared by the following procedures: 
10 
(a) Synthesis of a single-stranded cDNA bearing a tag substance 
Total RNA was extracted from 107 embryonic fibroblasts (MEF) 
prepared from the C3H line mouse using RNAeasy MiniKit (Qiagen) and 
poly(A) RNA was further extracted therefrom using Micro Fast Track Kit 
15 (Invitrogen). An oligo dT primer modified at the 5' end with biotin as a 
tag substance (a custom oligonucleotide synthesized by Invitrogen) was 
used together with the extracted poly(A) RNA as a template to synthesize 
a single-stranded cDNA bearing biotin at the 5' end relative to the 
single-stranded cDNA by using SuperScript First-Strand System 
20 (Invitrogen).  
(b) Synthesis of a double-stranded cDNA 
DNA polymerase I, Second-strand buffer and E. coli DNA ligase 
(all available from Invitrogen) were used together with the single-stranded 
25 cDNA as a template synthesized in the step (a) to synthesize a 
double-stranded cDNA bearing biotin at the 3'-end side relative to the 
double-stranded cDNA according to a method of double-stranded cDNA 
synthesis recommended by Invitrogen.  
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(c) Cleavage by a restriction enzyme X 
The double-stranded cDNA obtained in the step (b) was cleaved 
with Mspl as a first restriction enzyme X (TaKaRa) at 370 C for 4 hours.  
5 
(d) Recovery of a fragment bearing the tag substance 
A fragment bearing biotin was recovered from the double stranded 
cDNA fragments obtained in the step (c) using magnetic beads on which 
streptavidin as a substance having a high affinity for biotin was 
10 immobilized (DYNAL) according to the conditions recommended by 
DYNAL.  
(e) Ligation of an adaptor X 
To the cleavage site of the double-stranded cDNA fragment 
15 recovered in the step (d) by the restriction enzyme Mspl, the Mspl 
adaptor as an adaptor X containing a sequence complementary to the 
sequence of the cleavage site (a custom oligo synthesis by Invitrogen): 
(Base sequence of the Mspl adaptor) 
5'-AACACGAATGGCTACATGACACTCGGTT-3' (at the sense strand side 
20 of the double-stranded cDNA) (SEQ ID No.: 1); 
5'-CGAACCGAGTGTCATGTAGCCATTCGTGTT-3' (at the antisense 
strand side of the double-stranded cDNA) (SEQ ID NO.: 2), 
was ligated at 160C over 16 hours or more using T4 DNA Ligase (NEB 
(New England Biolabs)) to obtain a fragment ligated with the Mspl adaptor 
25 at the 5'-end side relative to the double-stranded cDNA.  
(f) Cleavage by a second restriction enzyme Y 
The fragment of the double-stranded cDNA recovered in the step 
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(e) was cleaved with Msel as a second restriction enzyme Y (NEB) at 
370C for 4 hours.  
(g) Recovery of a fragment containing the cleavage site by the second 
5 restriction enzyme Y 
The fragment bearing biotin was removed from the double 
stranded cDNA fragments obtained in the step (f) using magnetic beads 
on which streptavidin was immobilized (DYNAL) according to the method 
recommended by DYNAL, and the fragment containing the cleavage site 
10 by the second restriction enzyme Y was recovered. The obtained 
double-stranded cDNA fragment contained the Mspl adaptor at the 5' end 
and the cleavage site by the restriction enzyme Mspl at the 3' end.  
(h) Ligation of an adaptor Y 
15 To the cleavage site of the double-stranded cDNA fragment 
recovered in the step (g) by the restriction enzyme Msel, the Msel 
adaptor as an adaptor Y containing a sequence complementary to the 
sequence of the cleavage site (Custom Oligo Synthesis by Invitrogen): 
(Base sequence of the Msel adaptor) 
20 5'-AGTCACGAGTATCATACTGCGGGCGTCC-3' (at the antisense strand 
side of the double-stranded cDNA) (SEQ ID No.: 3); 
5'-TAGGACGCCCGCAGTATGATACTCGTGACT-3' (at the sense strand 
side of the double-stranded cDNA) (SEQ ID NO.: 4), 
was ligated at 250C for 16 hours or more using T4 DNA Ligase (NEB) to 
25 obtain a fragment ligated with the Msel adaptor at the 3'-end side relative 
to the double-stranded cDNA. Excessive amount of the adaptor was 
removed by precipitation using ethanol.  
25
(i) PCR reaction using primers X and Y 
(1) Synthesis of primers X and Y 
As a primer X, 16 different Mspl primers each composed of 20 
bases: 
5 (Base sequence of the Msel primer) 
5'-ACATGACACTCGGTTCGGN 1N2-3' 
(wherein N1N2 is CC, CT, CG, CA, TC, TT, TA, TG, AC, AA, AG, AT, GT, GC, 
GA, or GG) (SEQ ID NO.: 5) 
were synthesized depending on the kinds of N1N2 by the custom oligo 
10 synthesis (Invitrogen).  
As a primer Y, 16 different Msel primers each composed of 20 
bases: 
(Base sequence of the Msel primer) 
5'-ATACTGCGGGCGTCCTAAN 3N4-3' 
15 (wherein N3N4 is CC, CT, CG, CA, TC, TT, TA, TG, AC, AA, AG, AT, GT, GC, 
GA, or GG) (SEQ ID NO.: 6) 
were synthesized depending on the kinds of N3N4 according to the same 
method as the Mspl primer.  
Moreover, the Mspl primers were labeled with the fluorescent 
20 labeling substances named FAM, NED, or HEX by the custom oligo 
synthesis (Invitrogen).  
The resulting Msel primers (16 different types) and Mspl primers 
(16 different types) were combined to construct a total of 256 (16 x 16) 
different pairs of primers (primer sets).  
25 The Tm values of the primers constituting the 256 (16 x 16; Msel 
primers (16 different types) and Mspl primers (16 different types)) 
different primer sets in total were different depending on each sequence 
of 2 bases (N1 N2 for the primer X and N3 N4 for the primer Y) at the 3'-end 
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side. However the values were in the range of 60 0C to 64oC according 
to the above-described calculation formula (1). Consequently, the 
TmMax value was set at 640C.  
5 (2) PCR reaction 
The obtained 256 different primer sets were used to carry out a 
PCR reaction with the fragment of the double-stranded. sequence 
obtained in the step (h) as a template and TITANIUM Taq DNA 
Polymerase (Clontech) under the conditions described below. An 
10 optimum temperature of the polymerase used is in the range of 720C to 
74°C. The annealing temperature was 700C (TmMAX + 60C).  
The PCR conditions: 
At 950C for 1 min; 
(at 980C for 20 sec, at 70'C for 30 sec and at 72*C for 1 min) x 28 times; 
15 and 
at 600C for 30 sec.  
(j) Preparation of a gene expression profile 
PCR products obtained in the step (h) were subjected to 
20 electrophoresis using PRISM 3100 Capillary Electrophoresis Device 
(Applied Biosystems) according to the protocol recommended by POP4 to 
detect the migration distance and peaks. Based on the results of the 
electrophoresis, software GeneScanTM (Applied Biosystems, Japan) was 
used to prepare a gene expression profile showing the migration distance 
25 indicative of the molecular weight on the horizontal axis and the 
expression level indicative of the fluorescent intensity on the vertical axis.  
FIG. 2 shows a gene expression profile obtained by using a primer 
set composed of the following Mspl primer (primer X) and Msel primer 
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(primer Y): 
(Mspl primer) 5'-ACATGACACTCGGTTCGGCG-3' (SEQ ID NO.: 7); 
(Msel primer) 5'-ATACTGCGGGCGTCCTAATA-3' (SE1 ID NO.: 8).  
In FIG. 2, the vertical axis represents the fluorescent intensity of a 
5 peak indicating an amplified PCR product and correlates with the final 
quantity of the amplified PCR product. The horizontal axis represents 
the migration distance of the amplified PCR product and correlates with 
the number of nucleotide residues constituting the amplified PCR product 
(corresponding to a gene) of each peak. That is, the magnitude of a 
10 peak appearing in the profile shows the quantity of an amplified PCR 
product corresponding to the peak, i.e., the expression level of a gene 
corresponding to the amplified PCR product. Therefore, by observing 
changes in the magnitude of a particular peak, the frequency of the 
expression of the corresponding gene can be analyzed.  
15 
Example 2 
A primer set composed of primers X and Y shown below was used 
to prepare a gene expression profile for the mouse embryonic fibroblast 
(MEF) according to the steps similar to those in Example 1 except that 
20 the temperature for annealing the primers to templates was changed to 
70 0 C-76 0 C (in 10C increments).  
Mspl primer as the primer X (20 bases): 
5'-ACATGACACTCGGTTCGGTA-3' (SEQ ID NO.: 9); 
Msel primer as the primer Y (20 bases): 
25 5'-ATACTGCGGGCGTCCTAACC-3' (SEQ ID NO.: 10).  
Because the Tm of the Mspl primer was 600C and the Tm of the 
Msel primer was 64 0C according to the above-described calculation 
formula (1), the primer TmMAX was set to 640C. Thus, the annealing 
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temperature of 700C to 760C used in Example 2 corresponded to TmMAX 
+ 60C to TmMAX + 120C of the primer.  
Comparative Example 1 
5 The same primers used in Example 2 were used to prepare a 
gene expression profile for the mouse embryonic fibroblast (MEF) 
according to the steps similar to those in Example 2 except that the 
annealing temperature for the primers to templates was changed to the 
range of 670C (TmMAX + 30C) to 690C (Tm MAX + 50C) (in 10C 
10 increments).  
Test Example 1 
Regarding six peaks randomly extracted from the gene expression 
profiles obtained in Example 2 and Comparative Example 1 (however, 
15 each of the peaks corresponds to the expression of the identical gene in 
Example 2 and Comparative Exmaplel), the relationship between the 
annealing temperature and the fluorescent intensity of the peak is 
illustrated (FIG. 3A). In the figure, the horizontal axis represents the 
annealing temperature and the vertical axis represents the fluorescent 
20 intensity of the peak of the amplified PCR product (corresponding to the 
quantity of the amplified PCR product and thus to the expression level of 
the gene).  
The six peaks were roughly classified into 2 groups Group 1 and 
Group 2: in Group 1, peaks maintained high fluorescent intensity (high 
25 detection sensitivity) even at annealing temperatures of 700C or more (the 
legends in the figure: 0, 0, and A, where the numbers next to the 
legends show the degree of migration of an amplified PCR product 
corresponding to each peak (the value obtained from calibration by a 
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size-standard marker subjected to electrophoresis simultaneously with the 
amplified PCR product sample, that is, the value approximately equivalent 
to the length of a gene fragment corresponding to the amplified PCR 
product)); in Group 2, the fluorescent intensity of peaks decreased below 
5 a detection limit (the value of fluorescent intensity distinguishable from 
background) (i.e., the fluorescent intensity of 50 or less) at an annealing 
temperature of 700C (the legends in the figure: 0, IO, and O).  
Here, for evaluating the genuineness of each peak, the sequence 
of a PCR product corresponding to each peak was determined using 
10 PRISM 3100 Autosequencer. Based on the obtained base sequence, 
the genuineness of each peak was evaluated according to the 
above-described method for evaluating the genuineness of a peak.  
Incidentally, the existing database utilized in the evaluation was the 
publicly available mouse EST database (Genbank, EMBL, and DDBJ).  
15 As a result, it was found that the peak of Group 1 is a true peak 
composed of the amplified PCR product that satisfies all of the conditions 
(1) to (3) in the above-described method for evaluating the genuineness 
of a peak and that the peak of Group 2 is a false peak composed of the 
amplified PCR product that satisfies the conditions (1) to (2) but not the 
20 condition (3).  
These results indicate that, when the annealing of primers to 
templates in a PCR reaction is carried out at temperatures higher than 
TmMAX + 60C (64 0C + 60 C = 70'C) of the primer, it is possible to 
decrease false peaks, and when the annealing is carried out particularly 
25 in the temperature range of TmMAX + 60C (640C + 60C = 700C) to 
TmMAX + 90C (640C + 90C = 730C), it is possible to decrease false peaks 
while sufficiently maintaining the detection sensitivity of true peaks, 
resulting in further improvement in the detection sensitivity of the HiCEP 
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method.  
Example 3 
A primer set composed of primers X and Y shown below was used 
5 to prepare a gene expression profile for the mouse embryonic fibroblast 
(MEI-F) according to the steps similar to those in Example 1 except that 
the annealing temperature for the primers to templates was changed to 
700C-76°C (in 1C increments).  
Mspl primer as the X primer (20 bases): 
10 5'-ACATGACACTCGGTTCGGCG-3' (SEQ ID NO.: 1 ); 
Msel primer as the primer Y (20 bases): 
5'-ATACTGCGGGCGTCCTAATA-3' (SEQ ID NO.: 12).  
Because Tm of the Mspl primer was 64°C and the Tm of the Msel 
primer was 600C according to the above-described calculation formula (1), 
15 TmMAX of the primer was set at 640C. Thus, the annealing temperature 
of 700C to 76 0C used in Example 3 corresponded to TmMAX + 60C to 
TmMAX + 120C of the primer.  
Comparative Example 2 
20 The same primers used in Example 3 were used to prepare a 
gene expression profile for the mouse embryonic fibroblast (MEF) 
according to the steps similar to those in Example 3 except that the 
annealing temperature for the primers to templates was changed to the 
range of 650C (TmMAX + 10C) to 690C (TmMAX + 5°C) (in 1C 
25 increments).  
Test Example 2 
Regarding seven peaks randomly extracted from the obtained 
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gene expression profiles, the relationship between the annealing 
temperature and the fluorescent intensity of the peak is illustrated in the 
same manner as FIG. 3A (FIG. 3B).  
The seven peaks were roughly classified into 2 groups of Group 1 
5 and Group 2: in Group 1, peaks maintained high fluorescent intensity 
(high detection sensitivity) even at annealing temperatures of 700C or 
more (the legends in the figure: 0, 0, A, and *); and in Group 2, the 
fluorescent intensity of peaks decreased below a detection limit (the 
fluorescent intensity of 50 or less ) at an annealing temperature of 700C 
10 (the legends in the figure: O, 0, and A).  
The genuineness of each peak was evaluated in the manner 
similar to Test Example 1. As a result, it was found that the peak of 
Group 1 is a true peak composed of the amplified PCR product that 
satisfied all of the conditions (1) to (3) in the above-described method for 
15 evaluating the genuineness of a peak and that the peak of Group 2 is a 
false peak composed of the amplified PCR product that satisfied the 
conditions (1) to (2) but not the condition (3).  
These results indicate that, when the annealing of primers to 
templates in a PCR reaction is carried out at temperatures higher than 
20 TmMAX + 60C (640C + 60C = 700C) of the primer, it is possible to 
decrease false peaks, and when the annealing is carried out particularly 
in the temperature range of TmMAX + 60C (64 0 C + 60C = 70 0C) to 
TmMAX + 90C (640C + 90 C = 73 0C), it is possible to decrease false peaks 
while sufficiently maintaining the detection sensitivity of true peaks, 
25 resulting in further improvement in the detection sensitivity of the HiCEP 
method.  
Example 4 
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A primer set composed of primers X and Y shown below was used 
to prepare a gene expression profile for the mouse embryonic fibroblast 
(MEF) according to the steps similar to those in Example 1 except that 
the annealing temperature for the primers to templates was changed to 
5 70°C-760 C (in 10C increments).  
Mspl primer as the primer X (20 bases): 
5'-ACATGACACTCGGTTCGGTG-3' (SEQ ID NO.: 13); 
Msel primer as the primer Y (20 bases): 
5'-ATACTGCGGGCGTCCTAACC-3' (SEQ ID NO.: 14).  
10 Because Tm of the Mspl primer was 62 0C and Tm of the Msel 
primer was 64 0C according to the above-described calculation formula (1), 
primer TmMAX was set at 64 0C. Thus, the annealing temperature of 
70 0C to 76 0C used in Example 4 corresponded to TmMAX + 60C to 
TmMAX + 12°C of the primer.  
15 
Comparative Example 3 
The same primers used in Example 4 were used to prepare a 
gene expression profile for the mouse embryonic fibroblast (MEF) 
according to the steps similar to those in Example 4 except that the 
20 annealing temperature for the primers to templates was changed to the 
range of 67 0 C (TmMAX + 3°C) to 690C (TmMAX + 50C) (in 10 C 
increments).  
Test Example 3 
25 Regarding five peaks randomly extracted from the obtained gene 
expression profiles, the relationship between the annealing temperature 
and the fluorescent intensity of the peak is illustrated in the same manner 
as FIG. 3A (FIG. 3C).  
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The five peaks were roughly classified into 2 groups, Group 1 and 
Group 2: in Group 1, peaks maintained high fluorescent intensity (high 
detection sensitivity) even at annealing temperatures of 700C or more (the 
legends in the figure: N and 0); and in Group 2, the fluorescent 
5 intensity of peaks decreased below a detection limit (the fluorescent 
intensity of 50 or less) at an annealing temperature of 700C (the legends 
in the figure: O, A, and 0I).  
The genuineness of each peak was evaluated in the manner 
similar to Test Example 1. As a result, it was found that the peak of 
10 Group 1 is a true peak composed of the amplified PCR product that 
satisfied all of the conditions (1) to (3) in the above-described method for 
evaluating the genuineness of a peak and that the peak of Group 2 is a 
false peak composed of the amplified PCR product that satisfied the 
conditions (1) to (2) but not the condition (3).  
15 These results indicate that, when the annealing of primers to 
templates in a PCR reaction is carried out at temperatures higher than 
TmMAX + 60C (640C + 60C = 70 0C) of the primer, it is possible to 
decrease false peaks, and when the annealing is carried out particularly 
in the temperature range of TmMAX + 60C (640C + 60C = 700C) to 
20 TmMAX + 90C (640C + 90C = 730C), it is possible to decrease false peaks 
while sufficiently maintaining the detection sensitivity of true peaks, 
resulting in further improvement in the detection sensitivity of the HiCEP 
method.  
25 Industrial Applicability 
According to the present invention, the occurrence of false peaks 
resulting from the misannealing of primers in the process for preparing a 
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gene expression profile can be decreased. Thus, the detection 
sensitivity of expressed genes is improved, enabling preparation of a 
gene expression profile with high precision.  
The magnitude of a peak appearing on a gene expression profile 
5 prepared according to the present invention reflects the expression level 
of an expressed gene in a subject cell. Consequently, by observing 
changes in the magnitude of the peak, the frequency of gene expression 
can be analyzed. It is possible to carry out, for example, comparison 
between a normal cell and an abnormal cell, comparison between a 
10 normal cell and a canceer cell, comparison between different cells, and 
comparison between cells treated under different conditions.  
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Claims 
1. A method for preparing a gene expression profile, which 
comprises: 
5 (a) synthesizing a single-stranded cDNA by using a poly(A) RNA 
as a template, wherein a single-stranded cDNA bearing a tag substance 
at the 5'-end side relative to the single-stranded cDNA is synthesized; 
(b) synthesizing a double-stranded cDNA by using the 
single-stranded cDNA synthesized in the step (a) as a template, wherein 
10 a double-stranded cDNA bearing a tag substance at the 3'-end side 
relative to the double-stranded cDNA is obtained; 
(c) cleaving the double-stranded cDNA obtained in the step (b) 
with a first restriction enzyme X; 
(d) recovering a fragment bearing the tag substance from 
15 fragments obtained in the step (c) by using a substance having a high 
affinity for the tag substance; 
(e) ligating an adaptor X containing a sequence complementary to 
the sequence of the cleavage site and a sequence complementary to the 
sequence of a primer X to the cleavage site of the fragment generated by 
20 the first restriction enzyme X as recovered in the step (d), to obtain a 
fragment ligated with the adaptor X at the 5'-end side relative to the 
double-stranded cDNA; 
(f) cleaving the fragment recovered in the step (e) with a second 
restriction enzyme Y that does not cleave the adaptor X; 
25 (g) removing a fragment bearing the tag substance from the 
fragments obtained in the step (f) by using a substance having a high 
affinity for the tag substance, to recover a fragment containing the 
cleavage site generated by the second restriction enzyme Y at the 3'-end 
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side relative to the double-stranded cDNA; 
(h) ligating an adaptor Y containing a sequence complementary to 
the sequence of the cleavage site and a sequence complementary to the 
sequence of a primer Y to the cleavage site of the fragment generated by 
5 the second restriction enzyme Y as recovered in the step (g), to obtain a 
fragment of a double-stranded sequence ligated with the adaptor Y at the 
3'-end side relative to the double-stranded cDNA; 
(i) performing a PCR reaction with the fragment of the 
double-stranded sequence obtained in the step (h) as a template by using 
10 a primer set composed of a primer X containing a sequence 
complementary to the sequence of the adaptor X, which has the 
sequence of 2 bases N1 N2 (N 1 and N2 may be identical or different bases 
that are selected from the group consisting of adenine, thymine, guanine 
and cytosine) at the 3'-end side relative to the primer X, and a primer Y 
15 containing a sequence complementary to the sequence of the adaptor Y, 
which has the sequence of 2 bases N3 N4 (N3 and N4 may be identical or 
different bases that are selected from the group consisting of adenine, 
thymine, guanine and cytosine) at the 3'-end side relative to the primer Y; 
and 
20 (j) subjecting the obtained PCR product to electrophoresis and 
detecting the migration distance and peaks to prepare a gene expression 
profile, 
wherein, in the step (i), the annealing of the primer X and the 
primer Y to the adaptor X and the adaptor Y respectively is carried out in 
25 the temperature range of TmMAX + 60C to TmMAX + 140C of the primer.  
2. The method for preparing the gene expression profile according 
to claim 1, wherein, in the step (i), the annealing of the primer X and the 
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primer Y to the adaptor X and the adaptor Y respectively is carried out in 
the temperature range of TmMAX + 60 C to TmMAX + 90 C.  
3. The method for preparing the gene expression profile according 
5 to claim 1 or claim 2, wherein, in the step (i), 256 different primer sets 
composed of 16 different primers X and 16 different primers Y in 
combination are used as a primer set.  
4. The method for preparing the gene expression profile according 
10 to any of claim 1 to claim 3, wherein, in the step (i), 
the primer X is 
5'-ACATGACACTCGGTTCGGN 1 N2-3', 
wherein N1N2 is CC, CT, CG, CA, TC, TT, TA, TG, AC, AA, AG, AT, GT, GC, 
GA, or GG; and 
15 the primer Y is 
5'-ATACTGCGGGCGTCCTAAN 3N4-3', 
wherein N3N4 is CC, CT, CG, CA, TC, TT, TA, TG, AC, AA, AG, AT, GT, GC, 
GA, or GG.  
20 5. A method for analyzing the frequency of a gene expression, 
which comprises: 
(a) synthesizing a single-stranded cDNA by using a poly(A) RNA 
as a template, wherein a single-stranded cDNA bearing a tag substance 
at the 5'-end side relative to the single-stranded cDNA is synthesized; 
25 (b) synthesizing a double-stranded cDNA by using the 
single-stranded cDNA synthesized in the step (a) as a template, wherein 
a double-stranded cDNA bearing a tag substance at the 3'-end side 
relative to the double-stranded cDNA is obtained; 
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(c) cleaving the double-stranded cDNA obtained in the step (b) 
with a first restriction enzyme X; 
(d) recovering a fragment bearing the tag substance from the 
fragments obtained in the step (c) by using a substance having a high 
5 affinity for the tag substance; 
(e) ligating an adaptor X containing a sequence complementary to 
the sequence of the cleavage site and a sequence complementary to the 
sequence of a primer X to the cleavage site of the fragment generated by 
the first restriction enzyme X and recovered in the step (d), to obtain a 
10 fragment ligated with the adaptor X at the 5'-end side relative to the 
double-stranded cDNA; 
(f) cleaving the fragment recovered in the step (e) with a second 
restriction enzyme Y that does not cleave the adaptor X; 
(g) removing a fragment bearing the tag substance from the 
15 fragments obtained in the step (f) by using a substance having a high 
affinity for the tag substance to recover a fragment containing the 
cleavage site generated by the second restriction enzyme Y at the 3'-end 
side relative to the double-stranded cDNA; 
(h) ligating an adaptor Y containing a sequence complementary to 
20 the sequence of the cleavage site and a sequence complementary to the 
sequence of a primer Y to the cleavage site of the fragment generated by 
the second restriction enzyme Y as recovered in the step (g), to obtain a 
fragment of a double-stranded sequence ligated with the adaptor Y at the 
3'-end side relative to the double-stranded cDNA; 
25 (i) performing a PCR reaction with the fragment of the 
double-stranded sequence obtained at the step (h) as a template by using 
a primer set composed of a primer X containing a sequence 
complementary to the sequence of the adaptor X, which has the 
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sequence of 2 bases N1N2 (N1 and N2 may be identical or different bases 
that are selected from the group consisting of adenine, thymine, guanine 
and cytosine) at the 3'-end side relative to the primer X, and a primer Y 
containing a sequence complementary to the sequence of the adaptor Y, 
5 which has the sequence of 2 bases N3N4 (N3 and N4 may be identical or 
different bases that are selected from the group consisting of adenine, 
thymine, guanine and cytosine) at the 3'-end side relative to the primer Y; 
(j) subjecting the obtained PCR product to electrophoresis and 
detecting the migration distance and peaks to prepare a gene expression 
10 profile; and 
(k) analyzing changes of the frequency of the gene expression of 
a subject cell by comparing two gene expression profiles obtained in the 
steps (a) to (i), 
wherein, in the step (i), the annealing of the primer X and the 
15 primer Y to the adaptor X and the adaptor Y respectively is carried out in 
the temperature range of TmMAX + 60C to TmMAX + 140C of the primer.  
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